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Comparative characterization of cultured human term amnion
epithelial and mesenchymal stromal cells for application in cell
therapy
Abstract
Emerging evidence suggests human amnion tissue as a valuable source of two distinct types of
pluripotent cells, amnion epithelial cells (hAECs) and mesenchymal stromal cells (hAMSCs), for
applications in cell replacement therapy. For some approaches, it may be necessary to culture and
differentiate these cells before they can be transplanted. No systematic attempt has been yet made to
determine the quantity and quality of amnion cells after isolation and culture. We looked at amnion cell
isolates from 27 term placentas. Following our optimized protocol, primary yields were 6.3 x 10(6)
hAECs and 1.7 x 10(6) hAMSCs per gram amnion. All 27 cases gave vital cultures of hAMSCs, while
one third of cases (9 of 27) failed to give adherent cultures of hAECs. Primary cultures contained
significantly more proliferating than apoptotic cells (hAECs: 16.4% vs. 4.0%; hAMSCs: 9.5% vs.
2.4%). Neither hAECs nor hAMSCs were clonogenic. They showed slow proliferation that almost
stopped beyond passage 5. Microscopic follow-up revealed that hAEC morphology gradually changed
towards mesenchymal phenotype over several passages. Flow cytometric characterization of primary
cultures showed expression of mesenchymal progenitor markers CD73, CD90, CD105, and CD166, as
well as the embryonic stem cell markers SSEA-3 and -4 on both amnion cell types. These profiles were
grossly maintained in secondary cultures. Reverse transcriptase-PCR analysis exhibited transcripts of
Oct-3/4 and stem cell factor in primary and secondary cultures of all cases, but no telomerase reverse
transcriptase. Immunocytochemistry confirmed translation into Oct-3/4 protein in part of hAEC
cultures, but not in hAMSCs. Further, both amnion cell types stained for CD90 and SSEA-4. Osteogenic
induction studies with amnion cells from four cases showed significantly stronger differentiation of
hAECs than hAMSCs; this capacity to differentiate greatly varied between cases. In conclusion, hAECs
and hAMSCs in culture exhibit and maintain a similar marker profile of mesenchymal progenitors.
hAECs were found as a less reliable source than hAMSCs and altered morphology during subculture.
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Emerging evidence suggests human amnion tissue as a valuable source of two distinct types of pluripotent
cells, amnion epithelial cells (hAECs) and mesenchymal stromal cells (hAMSCs), for applications in cell
replacement therapy. For some approaches, it may be necessary to culture and differentiate these cells before
they can be transplanted. No systematic attempt has been yet made to determine the quantity and quality of
amnion cells after isolation and culture. We looked at amnion cell isolates from 27 term placentas. Following
our optimized protocol, primary yields were 6.3 × 106 hAECs and 1.7 × 106 hAMSCs per gram amnion. All
27 cases gave vital cultures of hAMSCs, while one third of cases (9 of 27) failed to give adherent cultures
of hAECs. Primary cultures contained significantly more proliferating than apoptotic cells (hAECs: 16.4%
vs. 4.0%; hAMSCs: 9.5% vs. 2.4%). Neither hAECs nor hAMSCs were clonogenic. They showed slow
proliferation that almost stopped beyond passage 5. Microscopic follow-up revealed that hAEC morphology
gradually changed towards mesenchymal phenotype over several passages. Flow cytometric characterization
of primary cultures showed expression of mesenchymal progenitor markers CD73, CD90, CD105, and
CD166, as well as the embryonic stem cell markers SSEA-3 and -4 on both amnion cell types. These profiles
were grossly maintained in secondary cultures. Reverse transcriptase-PCR analysis exhibited transcripts of
Oct-3/4 and stem cell factor in primary and secondary cultures of all cases, but no telomerase reverse
transcriptase. Immunocytochemistry confirmed translation into Oct-3/4 protein in part of hAEC cultures, but
not in hAMSCs. Further, both amnion cell types stained for CD90 and SSEA-4. Osteogenic induction studies
with amnion cells from four cases showed significantly stronger differentiation of hAECs than hAMSCs;
this capacity to differentiate greatly varied between cases. In conclusion, hAECs and hAMSCs in culture
exhibit and maintain a similar marker profile of mesenchymal progenitors. hAECs were found as a less
reliable source than hAMSCs and altered morphology during subculture.
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INTRODUCTION
It has become evident that various parts of human
placenta that are normally discarded after delivery con-
stitute valuable sources of maternal and fetal cells that
exhibit stem cell-like plasticity (9,14,16,26). Particular
attention has been directed to the amnion layer of the
deflected part of the fetal membranes as a source of
stem/progenitor cells of fetal origin. Amnion tissue is
derived from epiblast, which gives rise to all three germ
layers of the embryo. Because it is formed in the early
stage of embryogenesis, immature undifferentiated cells
may be reserved. Amnion contains two different cell
types: 1) amnion epithelial cells (hAECs), which form a
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continuous monolayer that contacts the amniotic fluid,
and 2) amnion mesenchymal stromal cells (hAMSCs),
which are sparsely distributed in the collagenous stroma
that underlies the amnion epithelium (20). Isolated
hAECs were found to express markers normally present
on embryonic cells or germ cells (14,15). Their differen-
tiation fates are beginning to be elucidated.
Emerging evidence suggest that amnion cells may be
differentiated into cells expressing markers of mesoder-
mal, endodermal, or ectodermal cells when stimulated
with singular or cocktails of specific differentiation fac-
tors in vitro. Characteristics of neural cells, pancreatic
β-cells, skeletal muscle, cardiomyocytes, or endothelial
cells could be induced in human amnion cells (1,14,23,
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29,31). Notably, some characteristics of other cell types
are intrinsically present in amnion cells [e.g., fresh iso-
lates of hAECs were found to show some characteristics
and functions of hepatocytes (28), and hAMSCs showed
characteristics of endothelial cells (1) as well as cardio-
myocytes (31)]. Other important advantages are that
hAECs are highly available, nonimmunogenic and even
immunosupressive (2,30), and do not form tumors after
allotransplantation (27). For these properties, hAECs
and possibly also hAMSCs, could become valuable trans-
gene carriers in cell therapy of inherited metabolic dis-
eases (18).
Transplantation of hAECs that were transduced before
in vitro with human low-density lipoporotein receptor
successfully reduced serum cholesterol in animals (27).
An appealing strategy would be their differentiation in
vivo, after transplantation: temporary normalization of
blood glucose levels was achieved after implantation of
freshly isolated hAECs into spleen of streptozotocin-
treated diabetic mice, suggesting that hAECs could ac-
quire β-cell fate in vivo (29). Important for transplanta-
tion approaches, human amnion cells have the capacity
to successfully and persistently engraft in vivo (2). Intra-
venous delivery of fresh, unfractionated human isolates
into newborn rats, or their interperitoneal delivery into
newborn swine, led to microcherism in multiple organs
and tissues.
Knowledge about yields, vitality, phenotype, and
expansion of hAECs or hAMSCs is a prerequisite for
therapeutic application. Systematic comparative investi-
gations have not yet been attempted. We have pre-
viously established protocols for isolation and culture of
hAECs or hAMSCs from term or preterm amnion tissue
with the goal to generate living tissue grafts for closure
of ruptured fetal membranes (3,4,19). Here we used
these methods for a first systematic side-by-side charac-
terization of hAECs versus hAMSCs regarding expan-
sion and stemness from 27 term placentas after isolation
and culture.
MATERIALS AND METHODDS
Isolation and Primary Culture of Term hAECs
and hAMSCs
Amnion tissues were collected immediately after
elective cesarean section from term placentas of gesta-
tional weeks 38 ± 0 (N = 27; between 37 and 39 weeks
of gestational age) in the absence of labor, PROM,
chorioamnionitis, or chromosomal abnormalities. Cases
in this study included repeat cesarean section (N = 16),
breech presentation (N = 8), and cephalo-pelvic dispro-
portions (N = 3). Amnion and chorion laeve tissues were
separated by blunt dissection (19), and the amnion was
cut approximately 2 cm from the placental disc to avoid
the “zone of altered morphology” (12,13). If not indi-
cated otherwise, reagents were purchased from Gibco
BRL (Basel, Switzerland).
To remove cellular debris and blood, the amnion
samples were washed in phosphate-buffered saline (PBS)
and treated with 0.25% trypsin for 3 min. This first di-
gestion supernatant, consisting primarily of red blood
cells, was discarded. hAECs were isolated by subse-
quent treatment of amnion tissue with 1.2 U/ml dispase
for 60 min at 37°C followed by gentle manual scraping
of the amnion epithelial surface with a cell scraper. The
complete removal of hAECs from amnion tissue was
validated by microscopic inspection of amnion tissue.
To isolate hAMSCs, the remaining amnion tissue was
minced and incubated with 2 mg/ml collagenase A
(Roche Diagnostics, Rotkreuz, Switzerland) for 120 min
at 37°C. Both cell types were cultured in a 1:1 mixture
of Ham’s F-12 and Dulbecco’s modified Eagle’s me-
dium (Ham’s F-12/DMEM) supplemented with 10%
heat-inactivated fetal bovine serum (FBS), 100 U/ml
penicillin, and 100 µg/ml streptomycin. In some experi-
ments, the amnion cells were cultured in medium addi-
tionally supplied with 10 ng/ml epithelial growth factor
(EGF) (Sigma, Buchs, Switzerland). Cultures were
grown near to confluence in a humidified incubator at
37°C and 5% CO2. Cell passage was performed using
trypsin-EDTA. In some experiments, human testicular
germ cell tumor (TGCT) cell line EP2102 cells served
as positive control (kindly provided by Dr. Thomas
Mueller, University of Halle, Halle, Germany).
Cell Size Determination
Cell areas of total 369 hAECs and 170 hAMSCs in
primary adherence culture from 10 different amnion
cases were measured. Cells were imaged with a DMIL
microscope (Leica, Glattbrugg, Switzerland) equipped
with a DML digital camera at day 4 of culture. Cell
size was measured using LeicaQ Win Image Analysis
software (Leica Imaging System Ltd, Cambridge En-
gland, UK).
Cell Proliferation and Apoptosis Assays
Cultured amnion cells were fixed with 3% paraform-
aldehyde (PFA) for 15 min at culture day 4, washed
three times with PBS, permeabilized with 0.2% Triton
X-100, and incubated with fluorescein isothiocyanate
(FITC)-labeled mouse monoclonal antibody Ki-67
(Zymed Laboratories, San Francisco, CA) at 4 µg/ml for
1 h at room temperature. Cells were washed three times
with PBS. Apoptosis was detected in primary cell cul-
ture at day 4 using the in situ TUNEL kit according to
the manufacturer’s instructions (Roche, Basel, Switzer-
land). Nuclei counterstaining was performed using
4′6-diamidino-2-phenylindole dihydrochloride (DAPI;
Molecular Probes, Eugene, OR). Fluorescing cells were
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imaged with a DMIL fluorescence microscope (Leica)
equipped with a DML digital camera (Leica). Cell
counts were obtained from fluorescence micrographs us-
ing automated image analysis software ImageJ 1.34s
(National Institute of Health, Bethesda, MD). Percent-
ages of proliferating or apoptotic cells are given. All
experiments were performed in triplicate.
Immunocytochemistry
hAECs and hAMSCs were fixed with 3% PFA for
15 min, washed three times with PBS, and permeabil-
ized with 0.2% Triton X-100. F-actin filaments were
visualized with rhodamine-labeled phalloidin (Molecu-
lar Probes). Nuclei were stained with DAPI. Fluorescing
cells were imaged with a DMIL fluorescence micro-
scope (Leica) equipped with a DML digital camera
(Leica). For SSEA-4, Oct-3/4, and CD90 detection,
hAECs and hAMSCs were cultured on collagen-coated
coverslips (Karl Hecht KG, Sondheim, Germany) and
fixed as described above. Cells were permeabilized
when needed, rinsed with PBS twice, blocked with 2%
bovine serum albumin (BSA) for 1 h, and quenched in
0.2 M glycine for 10 min. Samples were then incubated
with directly labeled tetramethylrhodamine isothiocya-
nate (TRITC)-conjugated primary monoclonal antibod-
ies (mAb) to: SSEA-4 (MC813-70), Oct-3/4 (240408)
(R&D Systems, Minneapolis, MN), or CD90 (5E10)
(BD Pharmingen, San Diego, CA) for 16 h at 4°C, and
then nuclei were counterstained with DAPI. The sam-
ples were rinsed with PBS and mounted in fluorescent
mounting medium (Dako, Carpinteria, CA). Analysis
was performed with fluorescent microscope Olympus
BX61 (Olympus, Hamburg, Germany) equipped with an
Olympus F-Few2 digital camera and analysed with anal-
ySIS 5.0 software (Olympus).
Flow Cytometry
Cells were collected by trypsinization. Reaction was
performed on live cells, using 105 cells per antibody re-
action. Cells were incubated for 45 min at 4°C. Antibod-
ies were used at a 1:50 dilution: mouse monoclonal anti-
bodies specific for MHC-I (G46-2.6), MHC-II (G46-6),
CD44 (G44-26), CD49e (IIA1), CD73 (AD2), CD90
(5E10), CD166 (3A6) (all from BD Pharmingen); CD34
(AC136), CD45 (5B1) (both from Miltenyi Biotec, Au-
burn, CA); CD105 (MEM-226) (Abcam, Cambridge,
UK), SSEA-3 (MAB 1434), SSEA-4 (MC813-70), STRO-
1 (STRO-1) (R&D Systems); CD117 (YB5.B8) (eBio-
scince, San Diego, CA, USA). Corresponding isotype
immunoglobulins (Ig) were used as negative controls
(Pharmingen; R&D). Primary mAbs were mostly di-
rectly labeled with FITC, TRITC, phycoerythrin (PE),
or allophycocyanin (APC). Where necessary, secondary
labeled goat or rat anti-mouse IgG1, anti-IgG2, and anti-
IgG3 (all from Pharmingen) were added for 45 min at
4°C. Cells were fixed in 4% buffered formalin and ana-
lyzed with a flow cytometer (FACSCalibur, Becton
Dickinson, Franklin Lakes, NJ). A minimum of 104
gated events were acquired for each sample.
Reverse Transcription-Polymerase Chain
Reaction (RT-PCR)
Total RNA was isolated using RNeasy Micro-kit
(Qiagen, Hilden, Germany). RNA concentrations were
measured by absorbance at 260 nm with a spectropho-
tometer (NanoDrop, Wilmington, DE), and 1 µg of
DNase I-treated RNA of each sample served as a tem-
plate for cDNA synthesis with ImProm-II Reverse Tran-
scription System (Promega, Madison, WI), before per-
forming PCR analysis. The cDNA templates were
amplified at 40 cycles of 95°C (35 s), 58°C (40 s), 72°C
(60 s), followed with 74°C for 5 min. PCR products
were visualized with ethidium bromide on a 1.5% agar-
ose gel. Primer sequences and product sizes are listed in
Table 1.
In Vitro Differentiation of hAECs and hAMSCs
Differentiation studies were performed with primary
cultures (P0) of hAECs and hAMSCs from four cases.
For that, cells were seeded at a density of 2 × 105 per
well in 48-well plates (Becton Dickinson). Finally, cells
were examined microscopically with a Zeiss Axiovert
200M (Carl Zeiss, Feldbach, Switzerland) equipped with
a digital camera (AxioCam MRc, Carl Zeiss) and ana-
lyzed with AxioVs40 V 4.5.0.0 imaging software (Carl
Zeiss).
Osteogenic Induction. Osteogenic differentiation was
performed as recommended by the manufacturer of the
osteogenic induction medium (Lonza, Walkersville, MD,
USA). hAECs and hAMSCs were maintained in ostege-
nic induction medium for 2 weeks, with fresh medium
added every third day. Control cultures were grown in
standard culture medium Ham’s F-12/DMEM supple-
mented with 10% FBS. Alkaline phosphatise (ALP) ex-
pression was demonstrated by cytochemical staining
with FAST BCIP/NBT (5-bromo-4-chloro-3-indolyl
phosphate/nitro blue tetrazolium) tablet (Sigma-Aldrich,
Buchs, Switzerland). For that, cells were fixed in pre-
cooled methanol for 5 min, rinsed with deionized water,
then incubated with FAST BCIP/NBT substrate for 10
min at room temperature. Finally, stained cells were
washed with water and examined microscopically.
Myogenic Induction. Myogenic differentiation was
performed as described previously (22). hAECs and
hAMSC were exposed to myogenic induction medium
composed of DMEM-H (Gibco), 10% FBS, 5% horse
serum, 50 µM hydrocortisone, and 0.1 µM dexametha-
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Table 1. Primers Used for Marker Expression Analysis (RT-PCR)
Marker Forward Primer Reverse Primer Product Size
hOct-3/4 GACAACAATGAAAATCTTCAGGAGA TTCTGGCGCCGGTTACAGAACCA 218 bp
hSCF GATGTTTTGCCAAGTCATTGTTGG ACTGACTCTGGAATCTTTCTCAGG 347 bp
hTERT AGAGTGTCTGGAGCAAGTTGC CGTAGTCCATGTTCACAATCG 185 bp
hActin CGGGAAATCGTGCGTGACAT GAACTTTGGGGGATGCTCGC 712 bp
sone for 1 week. Fresh media were added on day 3.
Control cultures were grown in DMEM-H/10% FBS.
For immunocytochemical staining, cells were washed
twice with PBS and fixed with 3% PFA for 15 min at
room temperature. Fixed cells were washed three times
with PBS and permeabilized with 0.2% Triton X-100.
Following this step, cells were rinsed twice with PBS
and blocked with 2% BSA for 1 h at room temperature.
Subsequently, cells were quenched with 0.2 M glycine
for 10 min. Thereafter cells were incubated with mouse
anti-human MyoD (5.8A) (Imgenex, San Diego, CA,
USA) or mouse anti-human myogenin (5FD) (Imgenex)
antibodies at dilution of 1:100 in 0.1% BSA for 1 h at
room temperature. Cells were washed and incubated
with Alexa Fluor 488-labeled secondary antibody (Mo-
lecular Probes) at dilution of 1:1000 in 0.1% BSA for 1
h at room temperature. Nuclei were counterstained with
DAPI. The samples were rinsed with PBS, mounted in
fluorescent mounting medium (Dako, Carpinteria, CA,
USA), and analyzed microscopically.
Adipogenic Induction. hAECs and hAMSCs were
exposed to adipogenic induction medium (Miltenyi Bio-
tec, Bergisch Gladbach, Germany) for 3 weeks, with
fresh media added twice weekly. Control cultures were
grown in standard culture medium Ham’s F-12/DMEM/
10% FBS. Oil Red O was utilized to visualize fat drop-
lets following the manufacturer’s instructions (Miltenyi
Biotec). Briefly, cells were washed twice with PBS,
fixed in precooled methanol for 5 min, rinsed with de-
ionized water, then incubated with Oil Red O (Sigma-
Aldrich) staining reagent for 20 min at room tempera-
ture. Finally, stained cells were washed with water and
analyzed microscopically.
Statistical Analysis
Data are shown as mean ± SEM. Two-tailed unpaired
t-test was performed using GraphPad Prism version 4.00
for Windows (GraphPad Software, San Diego, CA,
USA). Significance level was set at p < 0.05.
RESULTS
Outgrowth Characteristics and Vitality of Primary
Amnion Cell Cultures
Isolations were performed with term amnion (N = 27)
dissected from the deflected part of the fetal membranes.
We used a newly optimized two-step protocol that se-
quentially releases hAECs and hAMSCs from amnion.
This new protocol seeks to increase yield of vital cells
by avoiding the repeated harsh exposure of amnion cells
to trypsin (three to four times for 15 min) in the previous
protocol (3,4,19). The sequence of our new protocol
comprises a single short trypsinization step (3 min), fol-
lowed by treatment with the enzyme dispase, which is
known to produce less damage to cell membranes
(6,24). In a first step, we combined treatment of amnion
with 1.2 U/ml dispase and gentle mechanical scraping to
remove the epithelial layer. Optical inspection verified
complete recovery of all epithelial cells. In a second
step, the remaining amnion stroma was digested with 2
mg/ml collagenase A to obtain the hAMSC population.
Yields of live cells, as determined by trypan blue exclu-
sion, reproduced within a narrow range and assumed 6.3 ±
1.4 × 106 hAECs and 1.7 ± 0.3 × 106 hAMSCs per gram
of wet amnion tissue (Fig. 1A).
We selected for cell fractions capable of adhering to
culture dishes. In 9 out of 27 cases, hAECs completely
failed to attach after plating. In successful hAEC cul-
tures, only a small fraction of freshly isolated hAECs
attached and grew out. Seeding density was important
for hAECs: 1.75 × 105 cells/cm2 were found the minimal
seeding density required to give proliferating cultures.
hAMSC culture was successful in all 27 cases, and all
hAMSCs adhered within 16 h and could be further ex-
panded. For hAMSCs, a seeding density of 4 × 104 cells/
cm2 was sufficient. Rigorous optical inspection showed
that hAEC and hAMSC cultures were homogenous.
hAECs and hAMSCs greatly differ in shape, size, and
organization, which allows to assess culture homogene-
ity by phase contrast microscopy. Measurements of sin-
gle cell areas showed that hAMSCs were three times
larger than hAECs (i.e., 4266 ± 333 µm2 compared to
1403 ± 194 µm2 (Fig. 1B).
Figure 2A and D depicts the distinct morphologies
of hAECs and hAMSCs after overnight culture. hAECs
formed islands (Fig. 2A, arrowheads) with cell-to-cell
contact that subsequently grew out into cobblestone-like
epithelium (Fig. 2B), while hAMSCs did not form is-
lands and grew out from individual cells possessing ir-
regular shape and prominent cell protrusions (Fig. 2D
and E, arrows). The two cell types also exhibit very dif-
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Figure 1. Basic characteristics of hAECs and hAMSCs isolated at term. (A) Initial cell yields,
before plating, per gram of wet term amnion tissue (N = 18 amnion cases). The ratio of isolated
hAECs and hAMSCs was significantly different and was about 4:1. (B) Primary hAECs and hAMSCs
in adherent culture exhibit significantly different cell size. Cell size of hAMSCs was about three-
fold higher compared to hAECs (N = 10 amnion cases; n = 369 for hAECs and n = 170 for hAMSCs).
(C) Primary hAECs and hAMSCs exhibit similar vitality. For both amnion cell types, rates of
proliferating cells were significantly higher than rates of cells undergoing apoptosis. Proliferation
and apoptotic rates did not significantly differ between hAECs and hAMSCs. Rates of proliferating
(Ki-67 staining) or apoptotic cells (TUNEL staining) are expressed as percentages of total number
of cells (DAPI staining). N = 10 amnion cases. Values are mean ± SEM. *p < 0.05.
ferent actin organization in culture. Representative im-
ages of phalloidin-stained cultures in Figure 2C and F
show that hAECs exhibit cortical F-actin expression,
while hAMSCs have an extensive array of actin fila-
ments in their cytoplasm. Further, neither staining for
vimentin nor cytokeratin 18 expression were found spe-
cific for hAMSC and hAEC type in culture, respectively
(data not shown).
Ki-67 and TUNEL staining were used to identify pro-
liferating or apoptotic cells in primary cultures. For both
amnion cell types, rates of proliferating cells (hAECs:
16.4 ± 3.8%; hAMSCs: 9.5 ± 2.8%; N = 10 cases) were
significantly higher than rates of cells undergoing apo-
ptosis in the same culture (hAECs: 4.0 ± 1.0%; hAMSCs:
2.4 ± 0.5%) (Fig. 1C). Proliferation and apoptotic rates
did not significantly differ between hAECs and hAMSCs.
The primary amnion cells did not show any clonal out-
growth in high dilution seeding assays (data not shown).
Overall, proliferation in culture was slow. In our hands,
amnion cells could be serially passaged up to five times
(which took about 120 days) (Fig. 3A and B), at a low
splitting rate of 1:2 per passage. Although initial yields
of freshly isolated hAMSCs were approximately four
times lower than that of hAECs, comparable quantities
of hAECs and hAMSCs were obtained after subcultiva-
tion. Examination of cultures revealed that cell prolifera-
tion slowed down with every passage and almost stopped
beyond passage 5. The diagram in Figure 3A illustrates
minimal and maximal yields of cultured hAECs and
hAMSCs at indicated culture time points. We propose
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Figure 2. Primary hAECs and hAMSCs exhibit different morphology and outgrowth pattern in culture. Cell shape and cell organiza-
tion were analyzed by phase contrast microscopy and fluorescence microscopy to visualize phalloidin-stained F-actin cytoskeleton
(red) and DAPI-stained cell nuclei (blue). (A–C) hAECs formed and grew out in loose cell islands (A; arrowheads) that grew to
confluent cobblestone monolayer (B). hAECs exhibit cortical expression of filamentous actin (C). (D–F) hAMSCs grow out as
singular cells. Dense cultures showed cell protrusions towards neighboring cells (E; arrows). hAMSCs displayed strong expression
of F-actin throughout the cell (F). N = 5 amnion cases. Scale bar: 50 µm.
that hAECs from ≤passage 1, and hAMSCs from ≤pas-
sage 3 could be reasonable practical cell sources for
transplantation.
hAECs Gradually Assume Mesenchymal Morphology
During Subculture
An important point concerns whether the cells main-
tain their initial phenotype upon expansion in culture.
We looked at the morphology of serially passaged am-
nion cells from five cases by fluorescence microscopy
of phalloidine-stained cells. We observed that a striking
change of hAEC morphology over time: individual cell
area became enlarged and the regular cubic shape be-
came irregular. After three passages (day 50 in culture),
hAEC morphology became similar to that of culture-
expanded hAMSCs, suggesting epithelial–mesenchymal
transition. Figure 3B shows fluorescent microscopic fol-
low-up of cultures at days 7, 21, 30, 50, 90, and 120.
With every passage, the cortical actin expression pattern
of hAECS became more and more similar to the actin
expression pattern of AMSCs. At passage 5, the two cell
types were indistinguishably by morphology. Change of
hAEC morphology was slower when culture was per-
formed in the presence of 10 ng/ml EGF (data not
shown). For hAMSCs, no change of morphology was
observed throughout five passages.
Mesenchymal and Embryonic SC Marker
Profile of Primary hAEC and hAMSC Cultures
by Flow Cytometry
We used flow cytometry to screen the phenotypes of
primary cultured hAECs and hAMSCs. Figure 4 and
Figure 5A and B depict the results with hAECs and
hAMSCs from eight cases. hAECs and hAMSCs ex-
pressed high levels of HLA-ABC (MHC-I) but no HLA-
DR (MHC-II). Expression of HLA-ABC on hAECs was
significantly lower than on hAMSCs (p < 0.05) (Fig.
4A, B). As shown in Figure 5A–C, both cell types were
negative for hematopoetic markers CD34 and CD45.
Both amnion cell types were positive for surface mark-
ers of mesenchymal stromal (stem) cells (i.e., CD44,
CD49e, CD73, CD90, CD105, CD166, STRO-1), as
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well as embryonic stem cells SSEA-3 and -4. Some
hAMSC cultures showed weak expression of hemato-
poietic progenitor cell marker c-kit/CD117. While we
found little variation in levels of marker expression
within the individual cases, there were differences in ex-
pression levels of several markers between the hAEC
and hAMSC study groups. Expression of CD44, CD49e,
and CD90 was significantly higher on hAMSCs than on
hAECs (p < 0.05). Levels of CD73, CD166, and SSEA-
3 and -4 were significantly higher on hAECs (p < 0.05).
Subsequent analysis of marker profiles was per-
formed for secondary (passage 1) amnion cultures of all
eight amnion cases (Fig. 5C). There were no significant
changes in levels of marker expression between passage
0 and 1 on both cell types, except for embryonic marker
SSEA-4 on hAMSCs (p < 0.05). In one amnion case,
we monitored SSEA-4 levels on hAECs and hAMSCs
Figure 3. Morphology and yields of cultured hAECs and hAMSCs. (A) Minimal and maximal yields of cultured hAECs and
hAMSCs at indicated culture time points. hAECs from ≤passage 1, and hAMSCs from ≤passage 4 could be optimal sources for
transplantation. Gray background denotes potentially optimal harvest windows, based on grounds of stable cell morphology and
practical culture times. (B) Representative images showing the morphologies of hAECs and hAMSCs at indicated stages of culture,
from passage 0 to 5, over total 120 days. Cell shape was visualized by phalloidin staining of actin cytoskeleton. hAECs exhibit
typical epithelial morphology and growth pattern only at passages 0 and 1, but acquire hAMSC-like morphology upon further
passages. By contrast, there were no changes of hAMSC morphology over the full duration of culture. N = 5 amnion cases. Scale
bars: 25 µm.
over four passages, and we observed that numbers of
hAECs and hAMSCs positive for SSEA-4 epitope dur-
ing subculture dropped by 48% and 73%, respectively
(Fig. 5D).
“Stemness” Characteristics by RT-PCR
and Immunocytochemistry
By RT-PCR, we tested primary and secondary cul-
tures derived from eight cases for markers known to be
important for pluripotency or self-renewal of embryonic
stem cells. These included octamer-binding protein Oct-
3/4 (17), stem cell factor (SCF) (7), and telomerase re-
verse transcriptase (TERT) (7). Human testicular germ
cell tumor (TGCT) cell line 2102 EP was used as posi-
tive control. Cultures from all eight amnions were posi-
tive for transcripts of Oct-3/4 and SCF (Fig. 6A) but
negative for TERT. We next investigated by immunocy-
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Figure 4. Immunological marker profile of primary hAECs and hAMSCs. (A) Flow cytometry demonstrated that hAECs and
hAMSCs express HLA-ABC but not HLA-DR. (B) hAMSCs showed significantly higher expression of HLA-ABC than hAECs.
N = 8 amnion cases. *p < 0.05.
tochemistry whether Oct-3/4 transcripts translated into
Oct-3/4 protein (N = 5 cases). Figure 6B depicts repre-
sentative images. Nuclear expression of Oct-3/4 protein
was clearly detected in hAECs but undetectable in
hAMSCs. Interestingly, only two out of five hAECs cul-
tures were positive for Oct-3/4 protein, indicating bio-
logical disparity among amnion tissues from different
individuals. These two Oct-3/4-positive cases were also
positive for SSEA-4 on hAECs as well as on hAMSCs.
SSEA-4 was detected at sites of cell–cell contact. Fi-
nally, hAEC and hAMSC cultures from all five cases
were found positive for CD90 (Fig. 6B).
Differentiation Potential of hAMCs and hAMSCs
We performed functional differentiation assays to
look at whether expression of “stemness” markers in
these two amnion cell populations associated with a ca-
pability to differentiate. For that, we did a side-by-side
culture of hAECs and hAMSCs from four cases in os-
teogenic, adipogenic, or myogenic differentiation media.
Our analyses revealed significant osteogenic differentiation
of hAECs, but weak, insignificant osteogenic differentia-
tion of hAMSCs (Fig. 7). Neither hAECs nor hAMSCs
showed adipogenic or myogenic differentiation (not
shown). Figure 7A and B displays the results of our os-
teogenic assay. Cytochemical staining of ALP-positive
cells in culture showed that hAECs were significantly
more responsive to osteogenic induction than hAMSCs.
Still, broad disparity in osteogenic response between
hAECs from different cases became apparent. hAECs
from cases 1 and 2 exhibited significantly higher expres-
sion of ALP than hAECs from cases 3 and 4 (p < 0.05)
(Fig. 7A, B). In the two strong responders, cases 1 and
2, the proportions of ALP-positive cells were 53% and
63%, respectively. hAMSCs from all four cases showed
weak insignificant osteogenic differentiation. Less than
10% of cultured hAMSCs stained positive for ALP, and
these numbers were not significantly different from con-
trols.
DISCUSSION
Isolation of hAECs from term human amnion has be-
come an increasingly popular road for acquisition of pu-
tative stem cells for allotransplantation. Another road,
far less traveled, is isolation of hAMSCs from the col-
lagenous stroma of amnion. We studied the shared and
distinct properties of cultured hAMSCs and hAECs from
27 term placentas regarding their expansion and stem-
ness profile.
We found that outgrowth of hAMSCs is more reli-
able and morphologically more stable than hAECs. Both
amnion cell types showed slow proliferation in culture
and were not clonogenic, as expected by their lack of
TERT (Fig. 6A). Lower initial yields of hAMSCs than
hAECs (Fig. 3A) was found compensated during expan-
sion by better replating efficiency of hAMSCs. Stably
outgrowing hAMSCs were obtained from all 27 amnion
cases. By contrast, in a third of amnion cases, hAEC
culture was not successful because seeded cells did not
attach. Although we formally cannot exclude technical
problems upon isolation, our experience with amnion
cell culture over many years led us to propose that “no
outgrowth” behavior was for intrinsic biological reasons.
The failure of some hAEC isolates to attach in vitro
raises a potential concern also for direct transplantation
applications as cells might also fail to engraft in vivo,
but this remains to be investigated.
Cell therapy in a clinical setting will require cell
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Figure 5. Phenotype of primary (passage 0) and secondary (passage 1) hAECs and hAMSCs. The profiles represent systematic
screening of eight amnion cases. Cells were tested for indicated mesenchymal stem cells, embryonic stem cells, and hematopoietic
markers. (A) Representative FACS histograms of primary hAECs and hAMSCs. (B) Screen of primary cultured (P0) hAECs and
hAMSCs. Cells were positive for CD44, CD49e, CD73, CD90, CD105, CD166, STRO-1, SSEA-3, and SSEA-4, and negative for
hematopoetic markers CD34 and CD45. (C) Screen of passage 1 hAECs and hAMSCs. Marker expression profiles did not signifi-
cantly change from passage 0 to passage 1, except that of embryonic marker SSEA-4 on hAMSCs. *p < 0.05. (D) FACS monitoring
of SSEA-4 during subculture of hAECs and hAMSCs over four passages revealed gradual decrease of cell numbers positive for
SSEA-4. This analysis was performed for a single amnion case. P, passage.
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Figure 5. Continued.
numbers in the several hundred million range, rather
than a few million (8,11,25). Calculations from culture
data by us (Fig. 3A) and others (1) showed that subculti-
vation over several months will be necessary to accom-
plish several hundred millions of hAECs and hAMSCs
from a single amnion. However, long-term cell culture
is tedious, costly, and impractical in clinics. Further, we
caution about the utility of amnion cell products from
long-term culture. As documented in this study (Fig.
3B), subcultured hAECs undergo profound alteration
from epithelial to mesenchymal cell morphology; it was
also observed by others that cultured hAECs formed
multinucleated giant cells (14). Thus, we propose that
cell harvest at early passage 1 may be optimal, because
at this stage of culture the initial phenotype and mor-
phology of hAECs and hAMSCs is retained, which we
discuss below (Fig. 3).
Our definition of primary cultures from eight amnion
cases by flow cytometry revealed a very consistent phe-
notype for each amnion cell type (Fig. 5A, C). Although
greatly different by cell morphology and organization,
hAECs and hAMSCs exhibited remarkably similar sig-
nature regarding expression of surface antigens defining
mesenchymal stromal cells such as CD73, CD90,
CD105, CD166 (5,10), and concomitant lack of hemato-
poietic markers CD34 and CD45 and the immunologic
marker HLA-DR (MHC-II). The lower levels of HLA-
ABC (MHC-I) on hAECs pointed to potential superior
immunoprotection. Comparative profiling of cultures
demonstrated that phenotypes of both amnion cell types
were grossly maintained between passage 0 and passage
1 (Fig. 5B, C). Further, neither staining for vimentin nor
cytokeratin 18 expression were found specific for
hAMSC and hAEC type in culture, respectively. The
relation between these two amnion cell types in vivo
(e.g., if hAMSCs may derive from hAECs) is not clear.
Transmission electron microscopic studies of hAMSC
ultrastructure suggested an epithelial–mesenchymal hy-
brid phenotype (21), and in this study, we found that
hAECs gradually assume mesenchymal features during
subculture (Fig. 3B). Molecular discrimination at least
of cultured amnion cells will be possible in the future:
during the preparation of this manuscript, Wolbank et
al. published that CD49d (α4 integrin) is selectively ex-
pressed on cultured hAMSCs, but not on hAECs (30).
The search for stem cells in term human amnion in
vivo had suggested that hAECs, but not hAMSCs, ex-
press markers of pluripotency (15). Studies of isolated,
cultured hAECs indicated that some cells in the popula-
tion retain stem cell characteristics when allowed to
grow in clustered structures, whereas they seem to loose
their stem cell antigens when grown as “basal layer” di-
rectly attached to the culture dish (14). By these terms, the
adherent monolayer cultures in our study represent such
“basal layer.” Our data indicate that cultured hAMSCs
also express markers of undifferentiated cells. Flow cy-
tometry showed primary and secondary cultures of both
amnion cell types positive for SSEA-3, SSEA-4, and
STRO-1 in every tested amnion case (Fig. 5A, B). Im-
munocytochemistry confirmed the SSEA-4 epitope on
hAECs as well as hAMSCs, but only in two out of five
amnion cases (Fig. 6B), whereas the signal was beyond
immunocytochemical detection in three cases. Higher
sensitivity of flow cytometry versus immunocytochem-
istry is a possible explanation for this discrepancy. Like-
wise, Oct-3/4 transcripts were detected in every hAEC
and hAMSC primary and secondary culture tested (Fig.
6A), but by immunocytochemistry, Oct-3/4 protein was
found only in hAECs, and only in part of the amnion
cases. Possibly, cultured hAECs from different cases
contained hAECs at distinct state of differentiation. At
this point, it remains unclear whether Oct-3/4 protein
exists in cultured hAMSCs. We believe that caution is
necessary to interpret the presence of gene transcripts
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Figure 6. Immunoytochemistry and RT-PCR analysis of stem cell marker expression on amnion cells. (A) RT-PCR analysis for
Oct-3/4, SCF, and TERT transcripts in passage 0 and passage 1 amnion cells from eight amnion cases. All cultures showed
transcripts of Oct-3/4 and SCF, but not of TERT. The human TGCT cell line 2102 EP served as positive control. (B) Representative
fluorescence micrographs of primary hAECs and hAMSCs that were stained with antibodies specific for Oct-3/4, SSEA-4, or
CD90; nuclei were counterstained with DAPI. Five amnion cases were tested. Immunocytochemistry confirmed SSEA-4 and CD90
on hAECs as well as hAMSCs. Only hAECs were found positive for Oct-3/4. Of note, only two of five amnion cases stained
positive for SSEA-4 and Oct-3/4, indicating inherent heterogeneity among amnion cases as described in the Results section. Scale
bar: 25 µm.
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Figure 7. Side-by-side comparison of hAECs versus hAMSCs for ability to undergo osteogenic differentiation. Four cases were
examined. Cells were kept in osteogenic induction medium (+) or maintained without induction in standard medium (−). (A)
Osteogenic differentiation was visualized by colorimetric detection of ALP expression. (B) Percentage of ALP-positive cells to
total number of cells in culture. In three cases, hAECs were significantly more responsive to osteogenic induction than their
mesenchymal counterparts. Also, broad biological disparity between amnion cases regarding plasticity became evident. hAMSCs
from all four cases showed weak, insignificant differentiation. *p < 0.05. Scale bars: 100 µm.
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for prediction of stemness. By the criteria of Oct-3/4
expression, the epithelial population appears to be less
differentiated compared to the mesenchymal population.
Our studies of stemness in functional differentiation
assays suggest limited plasticity of amnion cell isolates,
at least under in vitro induction conditions. Our tests
for osteogenic, adipogenic, and myogenic differentiation
only showed osteogenic differentiation, which we found
strong and significant in hAECs but weak and insignifi-
cant in the corresponding hAMSCs (Fig. 7). Of further
note, our test with four amnion cases also points to great
disparity between hAECs from different cases regarding
plasticity. Together, while both hAECs and hAMSCs
exhibit very similar surface profiles of mesenchymal
progenitor, based on our in vitro data, hAECs appear to
possess much stronger mesodermal differentiation ca-
pacity than hAMSCs. In fact, our study could not pro-
vide any evidence of significant functional stemness of
hAMSCs.
In conclusion, it remains to be resolved whether end-
differentiated, functional cells can be produced from
both types of amnion cells in vitro or directly in vivo. A
central point for clarification will be whether controlled
differentiation can be accomplished and be scaled up to
a clinically relevant level.
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